Header Logo

Connection

JAMES P ALLISON to CD30 Ligand

Back to Details
This is a "connection" page, showing publications JAMES P ALLISON has written about CD30 Ligand.
JAMES P ALLISON
Connection Strength
0.147
CD30 Ligand
  1. Concurrent OX40 and CD30 Ligand Blockade Abrogates the CD4-Driven Autoimmunity Associated with CTLA4 and PD1 Blockade while Preserving Excellent Anti-CD8 Tumor Immunity. J Immunol. 2017 08 01; 199(3):974-981.
    View in: PubMed
    Score: 0.147
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.